These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18661420)

  • 1. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
    Newbold KL; Partridge M; Cook G; Sharma B; Rhys-Evans P; Harrington KJ; Nutting CM
    Acta Oncol; 2008; 47(7):1229-36. PubMed ID: 18661420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
    Breen SL; Publicover J; De Silva S; Pond G; Brock K; O'Sullivan B; Cummings B; Dawson L; Keller A; Kim J; Ringash J; Yu E; Hendler A; Waldron J
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):763-70. PubMed ID: 17379435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
    Dandekar P; Partridge M; Kazi R; Nutting C; Harrington K; Newbold K
    Indian J Cancer; 2010; 47(3):260-6. PubMed ID: 20587900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol.
    Berson AM; Stein NF; Riegel AC; Destian S; Ng T; Tena LB; Mitnick RJ; Heiba S
    Med Dosim; 2009; 34(1):30-5. PubMed ID: 19181253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
    Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
    Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
    Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
    Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
    J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area.
    Vogel WV; Schinagl DA; Van Dalen JA; Kaanders JH; Oyen WJ
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):74-83. PubMed ID: 17380097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
    Bosmans G; van Baardwijk A; Dekker A; Ollers M; Wanders S; Boersma L; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):139-44. PubMed ID: 17996384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
    Barker JL; Garden AS; Ang KK; O'Daniel JC; Wang H; Court LE; Morrison WH; Rosenthal DI; Chao KS; Tucker SL; Mohan R; Dong L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):960-70. PubMed ID: 15234029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
    van Baardwijk A; Bosmans G; Boersma L; Buijsen J; Wanders S; Hochstenbag M; van Suylen RJ; Dekker A; Dehing-Oberije C; Houben R; Bentzen SM; van Kroonenburgh M; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):771-8. PubMed ID: 17398018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.